Ischemic Stroke Clinical Trial
Official title:
Effect of Radial Shock Waves for the Treatment of Upper Limb Functional Disability in Stroke Sequelae
Verified date | June 2018 |
Source | University of Sao Paulo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This is a double blind randomized clinical trial to evaluate the effect of radial shock waves on functional recovery of the upper limb of patients with sequelae of ischemic strokes in the territory of the middle cerebral artery. A total of 20 patients will be enrolled and will undergo motor, functional and cortical excitability evaluations before and after four weekly sessions of radial shockwaves. 5,000 pulses with a frequency of 15 Hz and 3.5 to 4 bar of air pressure will be applied to the active group, resulting in an energy flux density (EFD) of approximately 0.07 mJ/mm2. The sham group will receive identical treatment, except for the fact that no energy flux will be applied.
Status | Completed |
Enrollment | 22 |
Est. completion date | February 2018 |
Est. primary completion date | February 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Clinical and radiological diagnosis: Magnetic Resonance Imaging (MRI) or Computed Tomography (CT) scan indicating Stroke in the territory of the middle cerebral artery; - 6 to 24 months after stroke date; - Stability observed in clinical medical evaluation - Granting of written informed consent to participate in the study Exclusion Criteria: - Individuals with a score lower than 24 on the Mini-mental test; - Previously documented strokes - Pregnancy - Patients treated with botulinum toxin, phenol, alcohol or previous surgeries six months before entering the study - Bone diseases, pre-existing joint damage, and deformities affecting the patient in a way to interfere with implementation of the proposed therapy - Psycho-affective disorder that prevents adherence - Joint pain that occurs within the movement range of therapies |
Country | Name | City | State |
---|---|---|---|
Brazil | Instituto de Medicina Fisica e Reabilitacao HCFMUSP | Sao Paulo |
Lead Sponsor | Collaborator |
---|---|
Marta Imamura |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Adverse Events (AE) | Accountability of occurences of Adverse Events | Weekly for two months | |
Primary | Fugl-Meyer Assessment (FMA) | Mean change in Fugl Meyer Assessment score after four sessions of Radial Shockwave Therapy (RSWT) as compared to baseline. | Change from baseline to 8 weeks | |
Secondary | Visual Analogue Scale (VAS) | Multiple changes in VAS | Baseline, one and two months | |
Secondary | Esthesiometry - Von Frey Scale | Multiple changes in Von Frey Scale | Baseline, one and two months | |
Secondary | Upper Limb Modified Ashworth Scale (MAS) | Multiple changes in MAS | Baseline, one week, two weeks, three weeks, four weeks and two months | |
Secondary | Fugl-Meyer Assessment | Changes in Fugl-Meyer Assessment compared to baseline | Baseline and two months | |
Secondary | Medical Research Council scale (MRC) | Multiple changes in MRC scale | Baseline, one and two months | |
Secondary | Hand grip | Multiple changes in Hand grip | Baseline, one and two months | |
Secondary | Change in fine motor function measured with Finger Tapping (FT) | Multiple changes in FT | Baseline, one and two months | |
Secondary | Jebsen-Taylor Hand Function Test (JTHFT) | Multiple changes in JTHFT | Baseline, one and two months | |
Secondary | Purdue Pegboard Test (PPBT) | Multiple changes in PPBT | Baseline, one and two months | |
Secondary | Robotic kinematic evaluation (RKE) | Multiple changes in RKE | Baseline, one and two months | |
Secondary | Corticospinal excitability measures with transcranial magnetic stimulation (TMS) | Multiple changes in Corticospinal excitability | Baseline, one and two months | |
Secondary | Pinch strength testing | Pinch strength testing | Baseline, one and two months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 |